U.S. Home Infusion Therapy Market Advancing Patient Care and Outcomes
The U.S. home infusion therapy industry is projected to rise from USD 19.56 billion in 2025 to USD 36.88 billion by 2035, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibiotics, pain management, or nutrition through an IV at home instead of a hospital. It’s a convenient, cost-effective option for chronic conditions, reducing hospital stays while ensuring safe, professional care from nurses or pharmacists.
Last Updated : 21 April 2026
Category: Therapeutic Area
Insight Code: 5102
Format: PDF / PPT / Excel